MPEP § 2413.01(b) — The “Sequence Listing XML” Must Be Valid According To the DTD (Annotated Rules)
§2413.01(b) The “Sequence Listing XML” Must Be Valid According To the DTD
This page consolidates and annotates all enforceable requirements under MPEP § 2413.01(b), including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
The “Sequence Listing XML” Must Be Valid According To the DTD
This section addresses The “Sequence Listing XML” Must Be Valid According To the DTD. Primary authority: 37 CFR 1.833 and 37 CFR 1.833(b)(1). Contains: 2 requirements and 1 other statement.
Key Rules
Sequence Listing Format
(b) The “Sequence Listing XML” presented in accordance with paragraph (a) of this section must further:
- (1) Be valid according to the Document Type Definition (DTD) as presented in WIPO Standard ST.26, Annex II.
37 CFR 1.833(b)(1) incorporates the DTD requirement of WIPO Standard ST.26 such that a “Sequence Listing XML” must conform to the Document Type Definition (the document that sets out the structure and use of elements and attributes in an XML compliant document) presented in Annex II of WIPO Standard ST.26. Use of the WIPO Sequence tool will enable a user to generate a “Sequence Listing XML” that conforms to the DTD in Annex II of WIPO Standard ST.26. See MPEP § 2418.
37 CFR 1.833(b)(1) incorporates the DTD requirement of WIPO Standard ST.26 such that a “Sequence Listing XML” must conform to the Document Type Definition (the document that sets out the structure and use of elements and attributes in an XML compliant document) presented in Annex II of WIPO Standard ST.26. Use of the WIPO Sequence tool will enable a user to generate a “Sequence Listing XML” that conforms to the DTD in Annex II of WIPO Standard ST.26. See MPEP § 2418.
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
| Sequence Listing Format | 37 CFR § 1.833(b)(1) |
| Sequence Listing Format | MPEP § 2418 |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2413.01(b) — The “Sequence Listing XML” Must Be Valid According To the DTD
Source: USPTO2413.01(b) The “Sequence Listing XML” Must Be Valid According To the DTD [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
37 CFR 1.833 Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022.
-
*****
- (b) The “Sequence Listing XML” presented in
accordance with paragraph (a) of this section must further:
- (1) Be valid according to the Document Type Definition (DTD) as presented in WIPO Standard ST.26, Annex II.
-
*****
37 CFR 1.833(b)(1) incorporates the DTD requirement of WIPO Standard ST.26 such that a “Sequence Listing XML” must conform to the Document Type Definition (the document that sets out the structure and use of elements and attributes in an XML compliant document) presented in Annex II of WIPO Standard ST.26. Use of the WIPO Sequence tool will enable a user to generate a “Sequence Listing XML” that conforms to the DTD in Annex II of WIPO Standard ST.26. See MPEP § 2418.